Path4Drug: Data Science Workflow for Identification of Tissue-Specific Biological Pathways Modulated by Toxic Drugs
暂无分享,去创建一个
[1] Fiona M. I. Hunter,et al. Drug Safety Data Curation and Modeling in ChEMBL: Boxed Warnings and Withdrawn Drugs , 2021, Chemical research in toxicology.
[2] Farizatul Akmawati Yahya,et al. A brief overview to systems biology in toxicology: The journey from in to vivo, in-vitro and –omics , 2021, Journal of King Saud University - Science.
[3] Daniel P. Morin,et al. Class 1C antiarrhythmic drugs in atrial fibrillation and coronary artery disease , 2020, Journal of cardiovascular electrophysiology.
[4] Adam J Pawson,et al. The IUPHAR/BPS Guide to PHARMACOLOGY in 2020: extending immunopharmacology content and introducing the IUPHAR/MMV Guide to MALARIA PHARMACOLOGY , 2019, Nucleic Acids Res..
[5] Feng Zhu,et al. Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics , 2019, Nucleic Acids Res..
[6] Thawfeek M. Varusai,et al. The reactome pathway knowledgebase , 2019, Nucleic Acids Res..
[7] A. Bleich,et al. Animal to human translation: a systematic scoping review of reported concordance rates , 2019, Journal of Translational Medicine.
[8] Ishani Shah,et al. Mifepristone: An Uncommon Cause of Drug-Induced Liver Injury , 2019, Gastroenterology research.
[9] Andrew R. Leach,et al. ChEMBL: towards direct deposition of bioassay data , 2018, Nucleic Acids Res..
[10] E. Paschetta,et al. Specialized Proresolving Mediators: Enhancing Nonalcoholic Steatohepatitis and Fibrosis Resolution. , 2018, Trends in pharmacological sciences.
[11] Subha Kalyaanamoorthy,et al. Development of Safe Drugs: The hERG Challenge , 2018, Medicinal research reviews.
[12] M. Moreno-Aliaga,et al. Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice , 2018, International Journal of Obesity.
[13] Ryan Miller,et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research , 2017, Nucleic Acids Res..
[14] David S. Wishart,et al. DrugBank 5.0: a major update to the DrugBank database for 2018 , 2017, Nucleic Acids Res..
[15] Henning Hermjakob,et al. The Reactome pathway knowledgebase , 2013, Nucleic Acids Res..
[16] Maria Jesus Martin,et al. The Proteins API: accessing key integrated protein and genome information , 2017, Nucleic Acids Res..
[17] Gary R. Mirams,et al. Systems Toxicology: Real World Applications and Opportunities , 2017, Chemical research in toxicology.
[18] Lincoln Stein,et al. Reactome pathway analysis: a high-performance in-memory approach , 2017, BMC Bioinformatics.
[19] Minoru Kanehisa,et al. KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..
[20] K. Tao,et al. Maresin 1, a Proresolving Lipid Mediator, Mitigates Carbon Tetrachloride-Induced Liver Injury in Mice , 2016, Oxidative medicine and cellular longevity.
[21] Robert Preissner,et al. WITHDRAWN—a resource for withdrawn and discontinued drugs , 2015, Nucleic Acids Res..
[22] Hui Zeng,et al. Drug-Path: a database for drug-induced pathways , 2015, Database J. Biol. Databases Curation.
[23] G. von Heijne,et al. Tissue-based map of the human proteome , 2015, Science.
[24] George Papadatos,et al. The ChEMBL bioactivity database: an update , 2013, Nucleic Acids Res..
[25] Robert Petryszak,et al. UniChem: a unified chemical structure cross-referencing and identifier tracking system , 2013, Journal of Cheminformatics.
[26] R. Altman,et al. Pharmacogenomics Knowledge for Personalized Medicine , 2012, Clinical pharmacology and therapeutics.
[27] Thorsten Meinl,et al. KNIME - the Konstanz information miner: version 2.0 and beyond , 2009, SKDD.
[28] A. Yuryev. In silico pathway analysis: the final frontier towards completely rational drug design , 2008, Expert opinion on drug discovery.
[29] B. Ganter,et al. Emerging applications of network and pathway analysis in drug discovery and development. , 2008, Current opinion in drug discovery & development.
[30] Division on Earth. Toxicity Testing in the 21st Century: A Vision and a Strategy , 2007 .
[31] J. Kapitulnik. Bilirubin: An Endogenous Product of Heme Degradation with Both Cytotoxic and Cytoprotective Properties , 2004, Molecular Pharmacology.
[32] I. Paakkari,et al. Cardiotoxicity of new antihistamines and cisapride. , 2001, Toxicology letters.
[33] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[34] H L Greene,et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. , 1991, The New England journal of medicine.